Acute myocardial infarction

Harvey White, Derek P Chew


Modern management of acute myocardial infarction is built on a clinical evidence base drawn from many studies undertaken over the past three decades. The evolution in clinical practice has substantially reduced mortality and morbidity associated with the condition. Key to this success is the effective integration of antithrombotic therapy combined with timely reperfusion, either primary percutaneous coronary intervention or fibrinolysis for ST-elevation myocardial infarction, and invasive investigation and revascularisation for non-ST-elevation myocardial infarction, underpinned by risk stratification and optimised systems of care. After the development of troponin assays for the detection of myonecrosis, the universal definition and classification of myocardial infarction now indicates the underlying pathophysiology. Additionally, an increasing appreciation of the importance of adverse events, such as bleeding, has emerged. Remaining challenges include the effective translation of this evidence to all patients with myocardial infarction, especially to those not well represented in clinical trials who remain at increased risk of adverse events, such as elderly patients and those with renal failure. On a global level, the epidem...Continue Reading


Aug 1, 1995·Circulation·E FalkV Fuster
Sep 2, 1993·The New England Journal of Medicine·UNKNOWN GUSTO investigators
Aug 5, 1993·The New England Journal of Medicine·UNKNOWN European Myocardial Infarction Project Group
Jun 23, 2001·The New England Journal of Medicine·C P CannonUNKNOWN TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis
Oct 1, 2003·The American Journal of Cardiology·Brahmajee K Nallamothu, Eric R Bates
Mar 15, 2005·European Heart Journal·Pedro de Araújo GonçalvesRicardo Seabra-Gomes
Apr 13, 2005·Circulation·Felicita Andreotti, Richard C Becker
Nov 3, 2005·Annals of Internal Medicine·Alexander M ClarkFinlay A McAlister
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Mar 16, 2006·The New England Journal of Medicine·UNKNOWN Fifth Organization to Assess Strategies in Acute Ischemic Syndromes InvestigatorsKeith A A Fox
Mar 16, 2006·The New England Journal of Medicine·Elliott M AntmanUNKNOWN ExTRACT-TIMI 25 Investigators
Sep 27, 2006·Archives of Internal Medicine·P Michael HoJohn S Rumsfeld
Nov 25, 2006·The New England Journal of Medicine·Gregg W StoneUNKNOWN ACUITY Investigators
Feb 15, 2007·JAMA : the Journal of the American Medical Association·Gregg W StoneUNKNOWN ACUITY Investigators
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Sean M DonahoeElliott M Antman
Oct 24, 2007·Circulation·Kristian ThygesenNawwar Al-Attar
Dec 7, 2007·JAMA : the Journal of the American Medical Association·Gregg W StoneUNKNOWN ACUITY Investigators
May 24, 2008·The New England Journal of Medicine·Stephen G EllisUNKNOWN FINESSE Investigators

❮ Previous
Next ❯


Jun 26, 2009·Der Anaesthesist·J RoggenbachP Teschendorf
May 6, 2011·Analytical and Bioanalytical Chemistry·Maciej CieslaJozef Dulak
Sep 5, 2009·Cardiovascular and Interventional Radiology·Yi-Liang LaiWei-Kuo Chang
Mar 17, 2010·Wiener medizinische Wochenschrift·Alois SuessenbacherHannes F Alber
Nov 13, 2012·Wiener medizinische Wochenschrift·Matthias K FreynhoferKurt Huber
Jul 8, 2010·Journal of Cardiovascular Translational Research·Vincent F M Segers, Richard T Lee
Jul 16, 2011·British Journal of Anaesthesia·D MokartJ L Blache
Feb 10, 2012·Cardiovascular Research·Rabea HinkelChristian Kupatt
Nov 30, 2010·European Heart Journal·Martina Perazzolo MarraSabino Iliceto
Aug 24, 2012·European Heart Journal·Emil L FosbølChristian Torp-Pedersen
Oct 16, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Alkystis PhinikaridouRené M Botnar
Jul 21, 2011·Physiological Genomics·J David PortCarmen C Sucharov
Aug 21, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Silvio AntoniakRafal Pawlinski
Jul 27, 2011·BMC Veterinary Research·Mounir BrihoumHélène Amory
Apr 9, 2009·Critical Care : the Official Journal of the Critical Care Forum·Yael ParanShlomo Berliner
Jan 31, 2014·Stem Cell Research & Therapy·Song-Yan Liao, Hung-Fat Tse
Mar 20, 2010·PloS One·Bernice WrightJonathan M Gibbins
Aug 25, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Harshawardhan M MardikarParag Admane
Jun 3, 2014·Biomedical Engineering Online·Lu ZhangShuqian Luo
Dec 24, 2013·Journal of Molecular and Cellular Cardiology·Joshua J Martindale, Joseph M Metzger
Aug 21, 2014·Postgraduate Medical Journal·Harvey D WhiteAllan S Jaffe
Sep 16, 2014·Neural Regeneration Research·Junping ZhangRuian Xu
Aug 12, 2014·TheScientificWorldJournal·Zhenci LiMinsheng Chen
May 8, 2014·Current Cardiology Reports·Harvey WhiteAllan Jaffe
Aug 28, 2014·Current Opinion in Cardiology·Rabea HinkelChristian Kupatt
Mar 11, 2010·Current Opinion in Critical Care·Jerry P Nolan, Jasmeet Soar
Nov 15, 2008·Shock·Thiruma V ArumugamTrent M Woodruff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

© 2022 Meta ULC. All rights reserved